Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
NEJM This Week
From NEJM Group
Health & Fitness
Clinical Conversations
by NEJM Group
Today: #132 in Health & Fitness, India on our combined chart.
Chart positions today · United States
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Clinical Conversations, try…
NEJM AI Grand Rounds
From NEJM Group
On Target
Also in Medicine
The NRG Oncology Podcast
Also in Medicine
Surgical Hot Topics
Also in Medicine
Prevention Playbook
Also in Medicine
Ranking history · United States
No ranking history for this show in United States over the last 14 days.
Latest episodes
-
Podcast 301: Monkeypox — what to look for, how to treat
August 19, 2022 · 17 minA VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. This time, we look to New York for guidance on recognizing and treating monkeypox. Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the…
-
Podcast 300: NADIM II trial offers “quite exciting” results in lung cancer
August 11, 2022 · 10 minA VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. We’re back with another interview from this year’s IASLC conference. This time, Christine Sadlowski and Dr. Julia Rotow interview Dr. Mariano Provencio about the survival outcomes…
-
Podcast 299: Lung cancer and atezolizumab — results from the IMpower010 trial
August 9, 2022 · 15 minA VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation for the Study of Lung Cancer (IASLC). As…
-
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2
August 2, 2022 · 14 minA VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter…
-
Podcast 297: Forget about all that vitamin D testing!!
July 28, 2022 · 13 minA VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Steven Cummings has co-written a take-no-prisoners editorial in the New England Journal of Medicine. The topic? Vitamin D supplements. The…
Show 7 more episodesShow fewer episodes
-
Podcast 296: A roundtable on the question, Why are young internists flocking to the hospitalist practice style?
July 20, 2022 · 30 minA VIDEO RECORDING OF THIS ROUNDTABLE IS AVAILABLE CLICK HERE. THE USUAL AUDIO FILE IS AVAILABLE BELOW Your host is old enough to remember when hospital corridors featured physicians with little black bags, scurrying around to see their…
-
Podcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?
July 6, 2022 · 16 minCREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe (but asymptomatic) carotid stenosis? Recent results suggest that medical management compares favorably with the surgical approach. In…
-
Podcast 294: PD-1 blockade in locally advanced rectal cancer
June 29, 2022 · 13 minLocally advanced rectal cancer usually receives a three-part treatment: chemotherapy followed by radiotherapy and then surgery. In a small-cohort study presented at this year’s ASCO conference researchers used a PD-1 inhibitor…
-
Podcast 293: HER2-“low” breast cancer and its reponse to an antibody-drug conjugate
June 27, 2022 · 11 minPatients with metastatic breast cancer whose tumors express low levels of HER2 are generally classified and treated as having HER2-negative disease. However, Dr. Shanu Modi of the Memorial Sloan Kettering Cancer Center and a group of…
-
Podcast 292: Informed consent and apnea testing for death — or — What is death, anyway?
June 17, 2022 · 15 minApnea testing is part of the protocol used to determine whether a patient is dead according to neurologic criteria. The question is, do clinicians need to obtain consent to proceed? In a fascinating 15-minute chat, two intensivists, Drs…
-
Podcast 291: Unionized nursing homes had lower mortality during Covid-19
May 24, 2022 · 13 minIn the early waves of the Covid-19 pandemic why did patients in unionized nursing homes, have a roughly 10% lower rate of mortality than those in non-unionized ones? A report in Health Affairs tries to sort out the possible…
-
Podcast 290: USPSTF’s new take on aspirin and primary prevention of CVD
May 8, 2022 · 15 minThe U.S. Preventive Services Task Force recently issued its sixth set of guidelines on using daily aspirin to prevent cardiovascular disease. The guidelines appeared in JAMA — whose editors asked our guest, Dr. Allan Brett, to write an…
About the show
From NEJM Journal Watch, this podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.